Plotkin's Vaccines

Name: Plotkin's Vaccines
Price: 132 USD
Availability: InStock
ISBN: 9780323790581

by Walter A. Orenstein, Paul A. Offit, Kathryn M. Edwards, Stanley A. Plotkin

8th Edition

Publisher: Elsevier

(0 reviews)

Immunology

Compare Prices

VitalSource180 Day Rental$132.00 AmazonHardcover$351.00 Best PriceeTextShelfPDF$38.00

Book Details

Print ISBN	9780323790581
eText ISBN	9780323790598
Publisher	Elsevier
Publishing Year	2023
Edition	8th Edition
Language	English
Pages	1808

Plotkin's Vaccines, 8th Edition, edited by Walter A. Orenstein, Paul A. Offit, Kathryn M. Edwards, and Stanley A. Plotkin, provides a comprehensive reference on the science and deployment of vaccines. Published by Elsevier, the work covers foundational vaccine immunology, manufacturing processes, safety protocols, and public health policies.

This edition includes all-new chapters dedicated to COVID-19, vaccine hesitancy, and the non-specific effects of vaccines. The text presents revised content on technological developments, incorporating material on mRNA vaccines, emerging vaccines, and systems aimed at improving immunization delivery and practice.

Recognized for professional quality and depth, the 8th edition was selected for Doody's Core Titles 2024, earning an Essential Purchase designation within Infectious Disease. The text supports practitioners and researchers evaluating modern immunization frameworks.

Chapter 1: A Short History of Vaccination
Chapter 2: Vaccine Immunology
Chapter 3: Non-specific Effects of Vaccines
Chapter 4: Correlates of Protection
Chapter 5: The Vaccine Industry
Chapter 6: Vaccine Manufacturing
Chapter 7: Evolution of Adjuvants Across the Centuries
Chapter 8: Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
Chapter 9: Passive Immunization
Chapter 10: General Immunization Practices
Chapter 11: Human Adenovirus Vaccines
Chapter 12: Anthrax Vaccines
Chapter 13: Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI)
Chapter 14: Cancer Vaccines
Chapter 15: Cholera Vaccines
Chapter 16: Combination Vaccines
Chapter 17: Coronavirus Vaccines
Chapter 18: Cytomegalovirus Vaccines
Chapter 19: Dengue Vaccines
Chapter 20: Vaccines Against Diarrhea Caused by Noncholera Bacteria
Chapter 21: Diphtheria Toxoid
Chapter 22: Ebola Vaccines
Chapter 23: Nonpolio Enteroviruses
Chapter 24: Epstein–Barr Virus Vaccines
Chapter 25: Haemophilus Influenzae Type b Vaccines
Chapter 26: Hepatitis A Vaccines
Chapter 27: Hepatitis B Vaccines
Chapter 28: Hepatitis C Vaccines
Chapter 29: Hepatitis E Vaccines
Chapter 30: Herpes Simplex Virus Vaccines
Chapter 31: Human Immunodeficiency Virus Vaccines
Chapter 32: Human Papillomavirus Vaccines
Chapter 33: Inactivated and Recombinant Influenza Vaccines
Chapter 34: Influenza Vaccine—Live
Chapter 35: Japanese Encephalitis Vaccines
Chapter 36: Lyme Disease Vaccines—the Journey Continues
Chapter 37: Malaria Vaccines
Chapter 38: Measles Vaccines
Chapter 39: Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
Chapter 40: Meningococcal Vaccines Directed at Capsular Group B
Chapter 41: Mumps Vaccines
Chapter 42: Noninfectious Disease Vaccines
Chapter 43: Norovirus
Chapter 44: Parasitic Disease Vaccines
Chapter 45: Pertussis Vaccines
Chapter 46: Plague Vaccines
Chapter 47: Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines
Chapter 48: Pneumococcal Polysaccharide Vaccines
Chapter 49: Poliovirus Vaccine—Inactivated
Chapter 50: Poliovirus Vaccine—Live
Chapter 51: Lyssaviruses and Rabies Vaccines
Chapter 52: Respiratory Syncytial Virus Vaccines and Monoclonal Antibodies
Chapter 53: Rotavirus Vaccines
Chapter 54: Rubella Vaccines
Chapter 55: Smallpox and Vaccinia
Chapter 56: Staphylococcus aureus Vaccines
Chapter 57: Streptococcus Group A Vaccines
Chapter 58: Streptococcus Group B Vaccines
Chapter 59: Tetanus Toxoid
Chapter 60: Tickborne Encephalitis Vaccines
Chapter 61: Tuberculosis Vaccines
Chapter 62: Typhoid Fever Vaccines
Chapter 63: Varicella Vaccines
Chapter 64: Yellow Fever Vaccine
Chapter 65: Zika Virus Vaccines
Chapter 66: Zoster Vaccines
Chapter 67: Technologies for Making New Vaccines
Chapter 68: Genetic-Based Vaccine Vectors
Chapter 69: Technologies to Improve Immunization
Chapter 70: Vaccination of Immunocompromised Hosts
Chapter 71: Vaccines for International Travel
Chapter 72: Vaccines for Healthcare Personnel
Chapter 73: Vaccination of Pregnant Women
Chapter 74: Immunization in the United States
Chapter 75: Immunization in Europe
Chapter 76: Immunization and Vaccine-Preventable Diseases in the Asia-Pacific Region
Chapter 77: Immunization in Low- and Middle-Income Countries
Chapter 78: Community Protection
Chapter 79: Economic Analyses of Vaccine Policies
Chapter 80: Regulation and Testing of Vaccines in the US
Chapter 81: Regulation of Vaccines in Europe
Chapter 82: Regulation of Vaccines in Low- and Middle-Income Countries
Chapter 83: Vaccine Safety
Chapter 84: Vaccine Hesitancy and Behavioral Factors Associated With Vaccine Uptake
Chapter 85: Legal Issues
Chapter 86: Ethics
Chapter 87: Vaccines to Prevent Mpox
Chapter APPENDIX: Websites and Applications for Mobile Devices With Information About Immunization